A detailed history of Mackenzie Financial Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Mackenzie Financial Corp holds 42,318 shares of TEVA stock, worth $724,060. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,318
Previous 95,118 55.51%
Holding current value
$724,060
Previous $1.34 Million 48.81%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$12.78 - $17.4 $674,784 - $918,719
-52,800 Reduced 55.51%
42,318 $687,000
Q1 2024

May 10, 2024

BUY
$10.67 - $14.43 $695,299 - $940,316
65,164 Added 217.55%
95,118 $1.34 Million
Q1 2023

Apr 24, 2023

SELL
$8.36 - $11.37 $9,639 - $13,109
-1,153 Reduced 3.71%
29,954 $265,000
Q4 2022

Feb 14, 2023

SELL
$7.95 - $9.48 $28,317 - $33,767
-3,562 Reduced 10.27%
31,107 $283,000
Q2 2022

Aug 10, 2022

BUY
$7.38 - $10.4 $17,335 - $24,429
2,349 Added 7.27%
34,669 $261,000
Q1 2022

May 13, 2022

SELL
$7.33 - $9.39 $159,398 - $204,194
-21,746 Reduced 40.22%
32,320 $303,000
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $13,801 - $17,801
1,747 Added 3.34%
54,066 $433,000
Q3 2021

Nov 08, 2021

BUY
$8.38 - $10.18 $263,056 - $319,560
31,391 Added 150.0%
52,319 $510,000
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $771,300 - $1.14 Million
-90,000 Reduced 81.13%
20,928 $189,000
Q2 2020

Aug 13, 2020

SELL
$8.12 - $13.12 $101,020 - $163,225
-12,441 Reduced 10.08%
110,928 $1.37 Million
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $685,330 - $1.38 Million
102,441 Added 489.49%
123,369 $1.11 Million
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $2.81 Million - $3.6 Million
-180,130 Reduced 89.59%
20,928 $328,000
Q4 2018

Feb 06, 2019

BUY
$14.59 - $23.84 $771,198 - $1.26 Million
52,858 Added 35.67%
201,058 $3.1 Million
Q3 2018

Nov 15, 2018

BUY
$21.06 - $25.65 $2.17 Million - $2.64 Million
103,000 Added 227.88%
148,200 $3.19 Million
Q1 2018

May 14, 2018

SELL
$16.68 - $22.07 $3.28 Million - $4.34 Million
-196,800 Reduced 81.32%
45,200 $772,000
Q4 2017

Feb 13, 2018

SELL
$11.23 - $19.1 $16.8 Million - $28.5 Million
-1,494,434 Reduced 86.06%
242,000 $4.59 Million
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $21.6 Million - $45.1 Million
1,402,230 Added 419.57%
1,736,434 $30.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
334,204
334,204 $11.1 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.